Drugs / glycopyrolate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02401074 Background | Nov 2018 → Jun 2020 | asthma | Lu Yuan Lee | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | glycopyrolate | “Premedication will consist of intramuscular glycopyrolate (0.2 mg), and midazolam (0.5-2.0 mg).” NCT02401074 ↗ |
| Route | Intramuscular | “intramuscular glycopyrolate” NCT02401074 ↗ |